Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease
NCT02216058
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
2000
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
NOYA CoCr Biodegradable Coating Sirolimus-Eluting Stent System
Sponsor
Medfavour (Beijing) Medical Co., Ltd